Pfizer Inc. sell Royal Bank of Canada
Start price
20.04.26
/
50%
€23.49
Target price
20.04.27
€21.27
Performance (%)
-1.98%
Price
24.04.26
€23.02
Summary
This prediction is currently active. With a performance of -1.98%, the SELL prediction for Pfizer Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 20.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pfizer Inc. | -1.98% |
| iShares Core DAX® | -1.741% |
| iShares Nasdaq 100 | 2.815% |
| iShares Nikkei 225® | -0.109% |
| iShares S&P 500 | 0.966% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer (PFE) had its "underperform" rating reaffirmed by Royal Bank Of Canada. They now have a $25.00 price target on the stock.
Ratings data for PFE provided by MarketBeat